IN2014DE03239A - - Google Patents

Info

Publication number
IN2014DE03239A
IN2014DE03239A IN3239DE2014A IN2014DE03239A IN 2014DE03239 A IN2014DE03239 A IN 2014DE03239A IN 3239DE2014 A IN3239DE2014 A IN 3239DE2014A IN 2014DE03239 A IN2014DE03239 A IN 2014DE03239A
Authority
IN
India
Prior art keywords
mannitol
weight
granulated composite
sorbitol
degree
Prior art date
Application number
Other languages
English (en)
Inventor
Yasuyuki Hirama
Naosuke Maruyama
Original Assignee
Shinetsu Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shinetsu Chemical Co filed Critical Shinetsu Chemical Co
Publication of IN2014DE03239A publication Critical patent/IN2014DE03239A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN3239DE2014 2013-11-15 2014-11-10 IN2014DE03239A (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013237000 2013-11-15

Publications (1)

Publication Number Publication Date
IN2014DE03239A true IN2014DE03239A (enExample) 2015-07-17

Family

ID=51951602

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3239DE2014 IN2014DE03239A (enExample) 2013-11-15 2014-11-10

Country Status (6)

Country Link
US (2) US20150141517A1 (enExample)
EP (1) EP2873415B1 (enExample)
JP (1) JP6307417B2 (enExample)
KR (1) KR102253849B1 (enExample)
CN (1) CN104644581A (enExample)
IN (1) IN2014DE03239A (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2016098459A1 (ja) * 2014-12-17 2017-09-28 株式会社ダイセル 遅延崩壊性粒子組成物
CA3131461C (en) 2019-04-03 2024-06-25 Akihiko Sasaki Pharmaceutical composition comprising gilteritinib and method of producing the same
CN115397469A (zh) * 2020-04-10 2022-11-25 日本瓦姆&珀巴尔株式会社 粘合剂
WO2021205887A1 (ja) * 2020-04-10 2021-10-14 日本酢ビ・ポバール株式会社 徐放性基剤
JP7724845B2 (ja) 2020-07-24 2025-08-18 エランコ・ユーエス・インコーポレイテッド イソオキサゾリン化合物及びその中間体を作製するための方法
JP7414668B2 (ja) * 2020-08-28 2024-01-16 信越化学工業株式会社 ポリビニルアルコール含有造粒物及び固形製剤
JP7590950B2 (ja) * 2020-12-18 2024-11-27 大鵬薬品工業株式会社 ビラスチンを含有する口腔内崩壊錠
KR20230146800A (ko) 2022-04-13 2023-10-20 주식회사 산흥이지 도로교통 표지판의 각도 조절장치
JP2023173283A (ja) * 2022-05-25 2023-12-07 フロイント産業株式会社 顆粒及びその製造方法、並びに錠剤
CN116510026B (zh) * 2023-07-04 2023-09-19 山东天力药业有限公司 一种甘露醇复合药用辅料及其制备方法
CN121941489A (zh) * 2023-10-12 2026-04-28 迪辅益制药有限及两合公司 用于制备附聚赋形剂颗粒的方法和系统

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3864406A (en) * 1973-04-25 1975-02-04 Suomen Sokeri Oy Process for the production of mannitol and sorbitol
EP1260215B1 (en) * 2000-03-01 2009-07-29 Eisai R&D Management Co., Ltd. Rapidly disintegrable tablet containing polyvinyl alcohol
JP3595765B2 (ja) * 2000-09-27 2004-12-02 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロースを含む乾式直打用基剤
JP4279220B2 (ja) * 2004-09-09 2009-06-17 日信工業株式会社 複合材料及びその製造方法、複合金属材料及びその製造方法
TWI383809B (zh) 2005-06-29 2013-02-01 Otsuka Pharma Co Ltd 含有西洛他唑（ｃｉｌｏｓｔａｚｏｌ）之口腔崩解粉末
CN102988318A (zh) * 2008-11-25 2013-03-27 田边三菱制药株式会社 口腔速崩片及其制备方法
JP5753661B2 (ja) 2009-01-26 2015-07-22 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロース水分散液を用いた湿式造粒打錠法
CN102548542B (zh) * 2009-08-11 2013-11-20 大日本住友制药株式会社 含有两种以上粒子的口腔速崩片
JP6073543B2 (ja) * 2010-07-08 2017-02-01 沢井製薬株式会社 ロラタジン含有口腔内崩壊錠の製造方法
CN103282051A (zh) * 2010-12-28 2013-09-04 大鹏药品工业株式会社 口腔内崩解片剂
JP2012236823A (ja) * 2011-04-28 2012-12-06 Fuji Chem Ind Co Ltd 耐湿安定性に優れた錠剤
AU2012326976B2 (en) * 2011-10-21 2017-08-17 Takeda Pharmaceutical Company Limited Sustained-release preparation
WO2013098576A1 (en) * 2011-12-31 2013-07-04 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Immediate release pharmaceutical composition of valsartan
EP2674149B1 (en) * 2012-06-15 2017-10-04 Shin-Etsu Chemical Co., Ltd. Method of preparing composite granule comprising low-substituted hydroxypropyl cellulose and rapid release preparation

Also Published As

Publication number Publication date
JP2015117240A (ja) 2015-06-25
KR20150056474A (ko) 2015-05-26
US20200038333A1 (en) 2020-02-06
US20150141517A1 (en) 2015-05-21
EP2873415B1 (en) 2018-08-29
US11723872B2 (en) 2023-08-15
CN104644581A (zh) 2015-05-27
KR102253849B1 (ko) 2021-05-21
JP6307417B2 (ja) 2018-04-04
EP2873415A1 (en) 2015-05-20

Similar Documents

Publication Publication Date Title
MX2013007057A (es) Metodos para producir composiciones farmaceuticas estabilizadas de dosis solida que contienen morfinanos.
WO2016014927A3 (en) Crystalline form of nicotinamide riboside
EP4248766A3 (en) Smokeless oral tobacco product and preparation thereof
MX2015008427A (es) Proceso de granulacion en seco para producir composiciones de comprimidos de metformina y sus composiciones.
MY187637A (en) Composite formulation for oral administration comprising ezetimibe and rosuvastatin
MX363347B (es) Sal de omecamtiv mecarbilo y proceso para preparar la sal.
EA201391053A1 (ru) Таблетка, диспергируемая в ротовой полости
EP4338803A3 (en) Process for the preparation of erythrocytes loaded with one or more substances of pharmaceutical interest and so obtained erythrocytes
EP4592275A3 (en) Hydrazinyl-pyrrolo compounds and methods for producing a conjugate
PH12016500043A1 (en) Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-andrenergic for administration by inhalation
HK1232218A1 (zh) Cgrp-活性化合物的片剂制剂
WO2014114255A3 (zh) 一种定位速释生物粘附剂及应用
NZ628451A (en) Dehydrated plant-derived products and methods for making the same
HK1214519A1 (zh) 雙用途硫酸鹽口服藥物組合物片劑及其使用方法
MX2016008527A (es) Preparaciones solidas que contienen tofogliflozina y proceso para producir las mismas.
NZ717101A (en) Partial melt co-crystallization compositions
IN2015DN00427A (enExample)
WO2014006636A3 (en) Stable compositions of fesoterodine
AU2013338098A8 (en) Solid salt form of alpha-6-mPEG6-O-hydroxycodone as opioid agonists and uses thereof
WO2014108918A3 (en) Injectable antifungal formulation
GEP201706769B (en) Composition of tiacumicin compounds
PH12014502170A1 (en) Drug composition and soft capsule drug sealing the drug composition
WO2015031198A3 (en) Bendamustine pharmaceutical compositions
MX346497B (es) Compuestos para la diferenciacion de celulas madre mejorada en hepatocitos.
MY182080A (en) Method for manufacturing thickener composition